Immunic Inc. buy Piper Sandler
Start price
17.07.24
/
50%
€1.33
Target price
17.07.25
€25.68
Performance (%)
9.25%
Price
17.09.24
€1.45
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 9.25%. This prediction currently runs until 17.07.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Immunic Inc. | 8.595% | 8.595% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by Piper_Sandler for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $28.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat